Status:
UNKNOWN
Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke
Lead Sponsor:
Fudan University
Conditions:
Stroke
Acute Ischemic Stroke
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
This study will determine if Angongniuhuang Pill (Composed of Niuhuang, Yujin, Xijiao, Huangqin, Huanglian, Xionghuang, Zhizi, Zhusha, Bingpian, Shexiang, and Zhenzhu) will have a better effect in res...
Eligibility Criteria
Inclusion
- Occurrence of an acute ischemic stroke (between 9 and 72 h after onset) with
- A score of not higher than 12 of Glasgow Coma Scale (GCS)
- Patient age of between 18 and 80 years.
- Patients or their representatives voluntarily take part in this study and signed the informed consent
Exclusion
- Transient Ischemic attack(TIA), cerebral hemorrhage, subarachnoid hemorrhage
- Ischemic stroke that needs rt-PA treatment
- Subjects who are unlikely to complete taking the investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.
- Pregnant or breast-feeding.
- Proven disability by law, such as blindness, deafness, dumb, disturbance of intelligence, mental disorders, limb handicap.
- Liable to be allergic (allergic to at lease 2 foods/drugs previously exposed)
- Had been participated in other clinical trials during the last 1 month prior to study inclusion.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00817609
Last Update
May 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200032